IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: The STANISLAS cohort

Atherosclerosis

Volumn 170, Issue 2, 2003, Pages 277-283

  Haddy, Nadia ^a   Sass, Catherine ^a   Droesch, Suzanne ^a   Zaiou, Mohamed ^b   Siest, Gérard ^a   Ponthieux, Anne ^a   Lambert, Daniel ^a   Visvikis, Sophie ^a  

^a Centre de Medecine Preventive   (France)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Atherosclerosis; Children; Healthy families; IL 6; Inflammation; Risk factors; TNF

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; L SELECTIN; LIPID; OROSOMUCOID; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FAMILY; FEMALE; HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGENY;

EID: 0242661399     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00287-9     Document Type: Article

References (46)

1. Ross R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340:1999;115-126.
2. Alexander R.W. Inflammation and coronary artery disease. New Engl. J. Med. 331:1994;468-469.
3. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among healthy men. Circulation. 101:2000;1767-7172.
4. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-{alpha} and increased risk of recurrent coronary events after myocardial infarction. Circulation. 101:2000;2149-2153.
5. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New Engl. J. Med. 347:2002;1557-1565.
6. Hwang S.J., Ballantyne C.M., Sharrett A.R., Smith L.C., Davis C.E., Gotto A.M. Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 96:1997;4219-4225.
7. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128:1998;127-137.
8. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 265:1990;621-636.
9. Mendall M.A., Patel P., Asante M., et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 78:1997;273-277.
10. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106:1999;506-512.
11. Ng S.B., Tan Y.H., Guy G.R. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J. Biol. Chem. 269:1994;19021-19027.
12. Jovinge S., Hamsten A., Tornvall P., et al. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism. 47:1998;113-118.
13. Ferrari R. The role of TNF in cardiovascular disease. Pharmacol. Res. 40:1999;97-105.
14. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br. Med. J. 321:2000;199-204.
15. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 349:1997;462-466.
16. Koenig W., Sund M., Frohlich M., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 99:1999;237-242.
17. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl. J. Med. 342:2000;836-843.
18. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 103:2001;1813-1818.
19. Engstrom G., Lind P., Hedblad B., Stavenow L., Janzon L., Lindgarde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 105:2002;2632-2637.
20. Tedder T.F., Steeber D.A., Chen A., Engel P. The selectins: vascular adhesion molecules. FASEB J. 9:1995;866-873.
21. Schumacher A., Seljeflot I., Sommervoll L., Christensen B., Otterstad J.E., Arnesen H. Increased levels of markers of vascular inflammation in patients with coronary heart disease. Scand. J. Clin. Lab. Invest. 62:2002;59-68.
22. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 10:1999;27-39.
23. Murakami T., Mataki C., Nagao C., et al. The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J. Atheroscler. Thromb. 7:2000;39-44.
24. Raab M., Daxecker H., Markovic S., Karimi A., Griesmacher A., Mueller M.M. Variation of adhesion molecule expression on human umbilical vein endothelial cells upon multiple cytokine application. Clin. Chim. Acta. 321:2002;11-16.
25. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143.
26. Siest G., Visvikis S., Herbeth B., et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin. Chem. Lab. Med. 36:1998;35-42.
27. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42:1986;121-130.
28. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of Interleukin-6 and the risk of future myocardial infarction among healthy men. Circulation. 101:2000;1767-1772.
29. Bermudez E.A., Rifai N., Buring J., Manson J.E., Ridker P.M. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arch. Pathol. Lab. Med. 22:2002;1668-1673.
30. Ray A., Prefontaine K.E., Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269:1994;12940-12946.
31. Pantsulaia I., Trofimov S., Kobyliansky E., Livshits G. Genetic and environmental influences on IL-6 and TNF-[alpha] plasma levels in healthy general population. Cytokine. 19:2002;138-146.
32. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in healthy men and women. J. Clin. Endocrinol. Metab. 86:2001;1154-1159.
33. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arch. Pathol. Lab. Med. 19:1999;972-978.
34. Ziccardi P., Nappo F., Giugliano G., et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 105:2002;804-809.
35. Marino M.W., Dunn A., Grail D., et al. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;8093-8098.
36. Mohamed-Ali V., Armstrong L., Clarke D., Bolton C.H., Pinkney J.H. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes. J. Intern. Med. 250:2001;415-421.
37. Leinonen E., Hurt-Camejo E., Wiklund O., Hulten L.M., Hiukka A., Taskinen M.R. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis. 166:2003;387-394.
38. Skoog T., Dichtl W., Boquist S., et al. Plasma tumour necrosis factor-[alpha] and early carotid atherosclerosis in healthy middle-aged men. Eur. Heart J. 23:2002;376-383.
39. Hulthe J., Wikstrand J., Mattsson-Hulten L., Fagerberg B. Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin. Sci. 103:2002;123-129.
40. Watson C., Whittaker S., Smith N., Vora A.J., Dumonde D.C., Brown K.A. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin. Exp. Immunol. 105:1996;112-119.
41. Haraldsen G., Kvale D., Lien B., Farstad I.N., Brandtzaeg P. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J. Immunol. 156:1996;2558-2565.
42. Demerath E., Towne B., Blangero J., Siervogel R.M. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann. Hum. Biol. 28:2001;664-678.
43. Fujita T., Hara A., Yamazaki Y. Relationship between circulating high density lipoprotein concentrations and interleukin-6 release during abdominal operations. Eur. J. Surg. 167:2001;347-350.
44. Ettinger W.H. Jr, Sun W.H., Binkley N., Kouba E., Ershler W. Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys. J. Gerontol. A Biol. Sci. Med. Sci. 50:1995;M137-M140.
45. Ettinger W.H., Varma V.K., Sorci-Thomas M., Parks J.S., Sigmon R.C., Smith T.K., Verdery R.B. Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. Arterioscler. Thromb. 14:1994;8-13.
46. Feister H.A., Auerbach B.J., Cole L.A., Krause B.R., Karathanasis S.K. Identification of an IL-6 response element in the human LCAT promoter. J. Lipid Res. 43:2002;960-970.